Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07407894
NA

iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

Sponsor: Synbiotic Health

View on ClinicalTrials.gov

Summary

This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.

Official title: VITAL-Age Trial (iVS-1 Investigation for Targeting Aging and Longevity)

Key Details

Gender

All

Age Range

40 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2026-02

Completion Date

2027-01

Last Updated

2026-02-27

Healthy Volunteers

Yes

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium adolescentis iVS-1

B. adolescentis iVS-1 (probiotic capsule) delivered orally once daily at a minimum of 8 billion CFU/day

DIETARY_SUPPLEMENT

Placebo

Placebo capsule delivered orally once daily

Locations (1)

MusB Research LLC

New Port Richey, Florida, United States